Stephen Hanauer to Receptors, Tumor Necrosis Factor
This is a "connection" page, showing publications Stephen Hanauer has written about Receptors, Tumor Necrosis Factor.
Connection Strength
0.090
-
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2001 Nov; 121(5):1088-94.
Score: 0.049
-
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis. 1999 May; 5(2):119-33.
Score: 0.041